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A simple method for classifying subjects as slow or rapid inactivators of isoniazid has
beenevaluated on large numbers of patients.Th  method consists of determining
the ratio of acetylisoniazid to isoniazid in a 24-26 h. urine collection following the
oral administration of a slow-release preparation of isoniazid 30 mg./kg. body-weight.
In a group of 101 patients, there was 100 per cent agreement between the classification
based on this method and that based on a standard method, consisting of estimation
of the serum isoniazid concentration, 4½ h. after an intramuscular dose of ordinary
isoniazid 3 mg./kg. body-weight.Subsequent studies in other patients have confirmed
that the method is efficient, and demonstrated that the classification is highly
reproducible.
Introduction
Methods for classifying subjects as slow or rapid inactivators of isoniazid on the
basis of the ratio of acetylisoniazid to isoniazid in urine following an intramuscular
or intravenous dose of isoniazid have been described by Eidus t al. (1971), Venkatara-
man et al. (1972) and Ellard et al. (1973b). Obviously, it would be far more
convenient, especially under field conditions, to administer the drug orally rather than
intramuscularly or intravenously.Recently, Ellard et al (1973a) reported, from their
 investigations on 20 patient-volunteers, that subjects could be conveniently classified
as slow or rapid inactivators by determining this ratio in a 24-25 h. urine collection
following the oral administration of a slow-release preparation of isoniazid (matrix
isoniazid, Smith and Nephew HS 82) in a dose of 30 mg./kg. body-weight.This paper
reports, on considerably larger numbers of patients, the findings of similar investiga-
tions with two doses of matrix isoniazid (30 mg./kg. and 37.5 mg./kg. body-weight).
Material and Methods
--
Patients: Adult tuberculous patients under treatment at the local Government
Tuberculosis Sanatorium, or under follow-up at the Tuberculosis Chemotherapy
1
2 Slow Rapid Inactivators of Isoniazid
Centre, were included in this investigation.The mean weight was 42 kg. for the former
and 43 kg. for the latter patients, the ranges being 25-60 kg. and 27-67 kg. respectively.
Test procedure : On the day of the test, a specimen of urine was collected from
the patient and tested for acetylisoniazid by the method of Eidus and Hamilton
(1964) (for patients under treatment, all antituberculosis drugs were withheld for at
least 24 h. before the test).After verifying that the result was negative, the dose of
matrix isoniazid was orally administered in the form of 300 mg. tablets (together with
pyridoxine 20 mg.), usually before breakfast.Next day, at 24 h., after the dose, the
patient was instructed to empty his bladder. At 26 h., a urine specimen was
collected from him, and the ratio of acetylisoniazid to isoniazid was determined.
Estimation of acetylisoniazid and isoniazid : Acetylisoniazid was estimated by the
direct method of Venkataraman et al. (1968), without prior oxidation using potassium
permanganate and without the reverse blank procedure*.Isoniazid was estimated by
the method of Rao et al. (1971).
Investigations : The first investigation was in 49 known slow inactivators and 52 known
rapid inactivators, who were under follow-up at this Centre. The isoniazid inactiva-
tion status of these patients had been determined previously by a standard method,
consisting of the estimation of the serum isoniazid concentration 4 h. after an
intramuscular dose of ordinary isoniazid 3 mg./kg. body-weight (Tuberculosis Chemo-
therapy Centre, Madras, 1973)].A dose of matrix isoniazid 30 mg./kg. body-weight
was administered to these patients, and. the 24-26 h. urine collections randomized
before they were processed. 
Subsequent investigations were undertaken in patients under treatment at the
sanatorium, matrix isoniazid doses of 30 mg./kg. and 37.5 mg./kg. body-weight being
administered to 97 and 193 patients, respectively.
Findings with the 30 mg/kg. dose :The findings of the investigation in known slow and
known rapid inactivators are illustrated in Graph 1. There was complete agreement
between the ‘known’ classification and that based on the ratio.Thus, ll the slow
inactivators had a ratio of less than 4 (highest value 3.4), whereas all the rapid inactiva-
tors had a ratio of more than 5 (lowest value 5.5).The mean ratio was 1.8 for the
slow inactivators and 15.7 for the rapid inactivators (P<10-5).
Graph 2 illustrates the findings in another series of 97 patients, whose isoniazid
inactivation status had not been ‘previously determined. The distribution clearly
demonstrates the presence of two groups of patients, and suggests that the criterion for
a rapid inactivator could be a ratio of 5 or more. Accordingly, 45 patients were
* Our subsequent experiencc indicates that it would be better to employ the extraction method of
Sarma et al. (1974), as the direct method fails if sugar ( > 25 mg./ml.) is present in the urine; fresh
criteria would, however, have to be derived for classification purposes.
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classified as rapid and 52 as slow inactivators.As in the first investigation, the mean
ratio for the rapid inactivators (13.2) was considerably higher than that for the slow
inactivators (1.6), the difference being highly significant (P < 10-5).
These findings clearly indicate that the ratio of acetylisoniazid to isoniazid in a
24-26 h. urine collection following a dose of matrix isoniazid 30 mg./kg. body-weight
would be a highly satisfactory measure for classifying patients as slow or rapid
inactivators, and that a ratio of 5 or more could be taken as the criterion for a rapid
inactivator.
Findings with the 37.5 mg./kg. dose :The distribution of 193 patients according to the
ratio of acetylisoniazid to isoniazid is illustrated in Graph 3.As with the 30 mg./kg.
dose, two distinct groups of patients, namely 110 slow inactivators (57 per cent) and
83 rapid inactivators (43 per cent), can be identified.The criterion for a rapid inactiva-
tor could again be taken as a ratio of 5 or more.The m an ratio was 14.7 for the rapid
and 1.4 for the slow inactivators (P<10-5).
Graph 3
Distribution of 193 patients according to the ratio of acetylisoniazid to isoniazid
in urine, 24-26 h. after a dose of matrix isoniazid 37.5 mg./kg.
Ratio of acetylisoniazid to isoniazid
Consistency of the test in classifying patients as slow inactivators or rapid inactivators :
There were 55 patients in the second and third investigations whose isoniazid inactivation
status had been determined on two occasions-following a dose of 30 mg./kg. on the
first occasion and a dose of 37.5 mg./kg. in the second occasion.The cl sification
on the two occasions was identical on all the 55 patients, 34 being classified as slow
inactivators and 21 as rapid inactivators.[An analysis of variance (not tabulated here)
of the ratios obtained on the 2 occasions showed that there were consistent differences
among the 34 slow inactivators, and among the 21 rapid inactivators].
Association between serum isoniazid concentration and ratio of acetylisoniazid to iso-
niazid : There was no association between the serum isoniazid concentration and the
ratio of acetylisoniazid to isoniazid in the 49 slow inactivators in the first investigation.
with the 30 mg./kg. dose.However, among the 52 rapid inactivators, the mean ratio
was 20.8 for 9 patients with a serum isoniazid concentration of less than 0.20 µg./ml.
compared with 14.8 for 43 patients with a concentration of 0.20-0.89 µg./ml.This
difference is significant (P=0.02), and indicates that there is heterogeneity among the
rapid inactivators.
Very rapid inactivators : In the second and third investigations, a total of 235 patients-
was investigated, and 128 (54 per cent) classified as slow inactivators (ratio <5) and
107 (46 per cent) as rapid inactivators (ratio > 5). Among the latter, 14 had very -high
ratios ( > 25) and were probably homozygous rapid inactivators. According to the
Hardy-Weinberg law, the expected number of homozygous rapid inactivators in this
population is 16.
Concluding remarks
The method described in this paper for classifying subjects as slow or rapid
inactivators of isoniazid is efficient and yields highly consistent findings.The method
is also convenient, for (a) the drug is administered orally, rather than intramus-
cularly or intravenously, and (b) no collection of blood is necessary, unlike the case
with several of the conventional methods for determining isoniazid inactivation
status. As both the doses investigated yielded efficient classification, the lower dose
(30 mg./kg.) is to be preferred.
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